Phathom Pharmaceuticals, Inc.
(PHAT - NASDAQ)
11,59 USD
📋 Profilo Aziendale

Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases.

|